FDAMA 114 and the 21st Century Cures Act

By Xcenda |
Insights Home
Xcenda presented an educational symposium on FDAMA 114 and the 21st Century Cures Act at ISPOR's 22nd International Meeting in Boston on May 23, 2017. Jay Jackson, PharmD, MPH, moderated a panel of experts to discuss insights from US payers and pharmaceutical manufacturers on the implications of the 21st Century Cures Act on the exchange of HCEI.

Related Content

Finding the Balance in Pharmaceutical Evidence Exchange With Payers and Providers

Jennifer Snow, MPH
August 2017

The Impact of Obesity on COVID-19 Outcomes of Hospitalizations and Mortality

Inverted color AmerisourceBergen icon
Xcenda
January 2021
outline of obese people with virus image

Patient Forward: Comparing ICER and PCORI's Use of Patient Feedback

Inverted color AmerisourceBergen icon
Xcenda
January 2021
Patient and doctor